RxDoctor Payments Data

David Orbuch

MOHS-Micrographic Surgery · Bethpage, NYNPI 1053843367

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $272 of the $371 with a category attached, or 73.3%. 4 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 54.0% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in NY, where the typical reported total is $1,291.

$371in general payments, 2019–2025

Across 10 payments — averaging $37.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$200
  • Johnson & Johnson$99
  • AbbVie$41
  • Cipher Pharmaceuticals US LLC$30

What the payments were for

  • Food & beverage$27273%
  • Education$9927%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron Healthcare Solutions, Inc.6$200
Johnson & Johnson1$99
AbbVie2$41
Cipher Pharmaceuticals US LLC1$30

How this compares

$371 in reported general payments places this provider in the 20th percentile of 75 mohs-micrographic surgery providers in New York.

See all mohs-micrographic surgery providers in New York

Medicare billing

Part B allowed, 2024
$890,247
Medicare patients
818
Services billed
5,185

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate145$6,461
Mupirocin530$3,806
Ketoconazole221$3,398
Metronidazole55$2,530
Triamcinolone Acetonide145$1,898
Clindamycin Phosphate33$992
Doxycycline Hyclate86$982
Econazole Nitrate20$610
Hydrocortisone92$609
ValacyclovirValacyclovir Hcl18$197
Cephalexin23$145

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Bethpage

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →